Cargando…
Membrane adsorption in vancomycin treatment is membrane type dependent in CVVHDF: dose correction is crucial
Autores principales: | Honore, Patrick M., Redant, Sebastien, Djimafo, Pharan, Preseau, Thierry, Cismas, Bogdan Vasile, Kaefer, Keitiane, Barreto Gutierrez, Leonel, Anane, Sami, Attou, Rachid, Gallerani, Andrea, De Bels, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052574/ https://www.ncbi.nlm.nih.gov/pubmed/35488349 http://dx.doi.org/10.1186/s13054-022-03991-5 |
Ejemplares similares
-
Difference of 11 years between two periods of VV-ECMO does not impact mortality in large centres: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2022) -
Endarterectomy treatment for patients suffering from a new episode of pulmonary embolism, after screening for chronic thromboembolic pulmonary hypertension
por: Honore, Patrick M., et al.
Publicado: (2022) -
PSP is a promising biomarker of sepsis; however, potential elimination by RRT must be considered
por: Honore, Patrick M., et al.
Publicado: (2022) -
Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects
por: Honore, Patrick M., et al.
Publicado: (2021) -
Is endocan correlated to ARDS severity or an epiphenomenon of thrombo-embolic disease in COVID
por: Honore, Patrick M., et al.
Publicado: (2021)